| CAS No.: | 58-63-9 |
|---|---|
| Formula: | C10h12n4o5 |
| Environmental Protection: | Yes |
| Color: | White Crystals or Crystalline |
| Classification: | Pharmaceutical Ingredients |
| Function: | Pharmaceutical Ingredients |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
Product Name: Inosine
Specification: 98.0%~102.0%
Appearance: White crystals or crystalline powder
| PRODUCT SPECIFICATIONS | ||
| Product Name: | Inosine | |
| CAS number | 58-63-9 | |
| Molecular formula | C10H12N4O5 | |
| ANALYSIS ITEMS | SPECIFICATION | TEST METHOD |
| Description | White crystals or crystalline powder; odorless; slightly bitter taste | |
| Identification |
|
|
| Transmission of solution | NLT 98.0% | |
| Loss on drying | ≤1.0% | |
| Residue on ignition | ≤0.2% | |
| Heavy metals(Pb) | ≤10ppm | |
| Assay | 98.0%~102.0% | |
| Packing | Pack in paper-drums and two plastic-bags inside N.W. 25 kgs I.D.35xH51cm. | |
| Storage | Store in a well-closed container away from moisture, light, oxygen. | |
| Shelf Life | 24 months under the conditions above and in its original packaging | |
2.In the treatment of acute hepatitis and chronic hepatitis and liver cirrhosis, hepatic encephalopathy.
3.Used for coronary atherosclerotic heart disease (coronary heart disease), myocardial infarction, rheumatic heart disease, cor pulmonale auxiliary drug use.
4. Used to prevent and mitigate the schistosomiasis prevention drugs caused by the heart and the liver toxicity.
5. Used for eye diseases (central retinal inflammation, optic atrophy) auxiliary drug use.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}